An observational study in End Stage Liver DIsease, Liver Transplantation and Old Age, sponsored by Azienda Ospedaliera di Padova. Recruiting at 1 site in Italy. Open to participants aged 71 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-04-24.
Sponsored by Azienda Ospedaliera di Padova · Observational
Increased life expectancy and aging population has led to a trend of increasing liver transplant (LT) volume in the elderly. Nowadays, advanced age is not considered an absolute contraindication for LT but elderly LT candidates typically have an age-associated burden of comorbid conditions that can pose several clinical challenges during the selection/evaluation process for LT. Specific algorithms for elderly patient selection for LT are not well established; however, consensus agreement is that elderly LT candidates need a more rigorous selection process.
This study proposes a "step by step" algorithm of selection for liver transplant candidates more than 70 years.
2,083 studies on the registry are indexed under Liver Diseases; 392 are open to participants now.
This study's planned enrollment of 18 is below the median of 167 across 683 observational studies indexed under Liver Diseases.
Browse Liver Diseases studies →Azienda Ospedaliera di Padova is the lead sponsor of 36 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Consecutive candidates for liver transplant with age >70 and ≤ 75 years
Exclusion Criteria:
Liver transplantation
1 year patient survival
Overall patients survival at 12 months from liver transplantation
Time frame: 12 months
1 year graft survival
Overall graft survival at 12 months from liver transplantation
Time frame: 12 months
3 months mortality and morbidity
Mortality and morbidity rates at 3 months from liver transplantation
Time frame: 3 months
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Azienda Ospedaliera di Padova